Related Experiment Video
Updated: Mar 26, 2026

A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
Published on: January 9, 2026
Clinical and pathophysiological issues associated with type 1 autoimmune pancreatitis
Kazushige Uchida1, Hideaki Miyoshi2, Tsukasa Ikeura2
1Department of Gastroenterology and Hepatology, Kansai Medical University, 10-15 Shinmachi, Hirakata, Osaka, 573-1010, Japan. uchidak@hirakata.kmu.ac.jp.
Autoimmune pancreatitis (AIP) has two types: type 1, linked to IgG4-related disease (IgG4-RD), and type 2. This overview focuses on type 1 AIP, highlighting recent advancements and remaining challenges in its clinical and basic understanding.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Autoimmune pancreatitis (AIP) concept introduced in 1995.
- AIP comprises two subtypes: type 1 (IgG4-related disease manifestation) and type 2 (granulocytic epithelial lesions).
- Type 2 AIP is considered rare in Japan.
Purpose of the Study:
- To provide an overview of recent clinical and basic issues concerning type 1 AIP.
- To discuss advancements in understanding type 1 AIP's clinical features, diagnosis, treatment, and pathogenesis.
- To identify unresolved clinical and basic challenges in type 1 AIP.
Main Methods:
- Review of recent clinical and basic research on type 1 AIP.
- Analysis of diagnostic criteria, including International Consensus Diagnostic Criteria (ICDC) and Japan Pancreas Society (JPS) 2011 criteria.
- Synthesis of current knowledge on IgG4-related disease (IgG4-RD) in the context of type 1 AIP.
Main Results:
- Significant progress has been made in understanding type 1 AIP's clinical features, diagnosis, treatment, and pathogenesis.
- The Japan Pancreas Society (JPS) 2011 criteria, based on ICDC, simplify type 1 AIP diagnosis.
- Despite advancements, numerous clinical and basic questions regarding type 1 AIP persist.
Conclusions:
- Type 1 AIP, a manifestation of IgG4-related disease, requires ongoing research.
- Further investigation is needed to address the remaining clinical and basic issues in type 1 AIP.
- Continued efforts are essential for improving the diagnosis and management of type 1 AIP.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

